Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-05

FDA Approved: MESALAMINE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved the original application for mesalamine from Zydus Lifesciences Limited, confirming the generic product for inflammatory bowel disease indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)